Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the comensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 539394 0 FOR 539394 FOR Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 0 0 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES 0 0 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES 7162637 0 FOR 7162637 FOR ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES 7162637 0 1 YEAR 7162637 FOR Relay Therapeutics Inc 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES 4010774 0 FOR 4010774 FOR Silence Therapeutics Plc 82686Q101 US82686Q1013 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 0 0 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0 0 Zymeworks, Inc. 98985Y108 US98985Y1082 12/30/2025 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1113946 0 FOR 1113946 FOR